Evidence map›Paper›PMID 40649191›Full record

ReviewMolecules (Basel, Switzerland)2025

Chemical Modification Methods for Inulin- and Agavin-Type Fructans: Synthesis, Characterization, and Biofunctional Activity: A Review.

Dafne I Díaz-Ramos, Maribel Jiménez-Fernández, Oscar García-Barradas, Rosa Isela Ortiz-Basurto, Benoit Fouconnier

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dafne I Díaz-RamosCentro de Investigación y Desarrollo en Alimentos, Universidad Veracruzana, Xalapa 91190, Veracruz, Mexico.ORCID 0000-0002-8112-5707
Maribel Jiménez-FernándezCentro de Investigación y Desarrollo en Alimentos, Universidad Veracruzana, Xalapa 91190, Veracruz, Mexico.ORCID 0000-0001-5437-3812
Oscar García-BarradasInstituto de Química Aplicada, Universidad Veracruzana, Xalapa 91190, Veracruz, Mexico.ORCID 0000-0001-8986-7214
Rosa Isela Ortiz-BasurtoLaboratorio Integral de Investigación en Alimentos, TecNM-Instituto Tecnológico de Tepic, Tepic 63175, Nayarit, Mexico.ORCID 0000-0002-8284-4690
Benoit FouconnierFacultad de Ciencias Químicas, Universidad Veracruzana, Coatzacoalcos 96538, Veracruz, Mexico.ORCID 0000-0001-5286-6517

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inulin and agavin fructans have been widely used in the food industry as fat substitutes, wall materials, and prebiotics, among other applications. Chemical modifications offer several advantages, from enhancing functional properties to broadening industrial applications, making them a key area of research in biotechnology, nutrition, and food science. This review examines the chemical modifications of fructans, specifically the inulin and agavin types. It describes the most commonly used methods, their characteristics, and their impact on the physicochemical, functional, and prebiotic properties of fructans. Additionally, it explores the interactions underlying these changes. Modifications enhance, extend, or generate new biological properties and activities. While most yield positive outcomes, challenges remain, including a deeper understanding of the structure-bioactivity relationships and further toxicity assessments, particularly in agavins. These insights aim to guide future research and innovation in the field.

Indexed as

FructansInulinAnimalsHumansPrebioticsFructansInulinPrebioticschemical methodsfructansfunctionalitymodificationstructure

Identifiers

PMID40649191
PMCPMC12251432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.